Skip to main content Back to Top

Marie A. Chisholm-Burns

Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FACHE, FASHP, FAST ([email protected]) is the executive vice president and provost of Oregon Health & Science University (OHSU) and the J.S. Reinschmidt Endowed Professor in the OHSU School of Medicine. She is also founder and director of the Medication Access Program, which has helped thousands of solid-organ transplant recipients receive more than $119 million in prescription medications.

Chisholm-Burns received her BS in pharmacy and Doctor of Pharmacy degrees from the University of Georgia, Master of Public Health degree from Emory University, Master of Business Administration degree from the University of Memphis, and PhD degree from the University of South Dakota. She completed her residency at Piedmont Hospital in Atlanta, Georgia. She has also achieved FACHE certification and practiced in several regions of the U.S.

Chisholm-Burns has been an active member of ASHP for over 30 years. She previously served in several ASHP leadership positions; for example, she served as the inaugural chair of the ASHP Section of Pharmacy Educators Executive Committee, as director-at-large of the ASHP Section of Clinical Specialists and Scientists Executive Committee, as a member of the Center for Health-System Pharmacy Leadership Advisory Panel, and as a member of the AJHP editorial board. She is a member of the Pharmacy Forecast Advisory Committee and contributed to several Forecasts over the years, including 2024 (public health priorities), 2023 (health disparities), and 2021 (healthcare access). Additionally, Chisholm-Burns has received several awards from ASHP, including the 2022 Board of Directors’ Distinguished Leadership Award.

Meet Marie A. Chisholm-Burns

Equitable healthcare access and delivery are of utmost importance to the health of our communities. Access and success are central to my vision for pharmacy practice – specifically, access to healthcare and success in achieving health equity and optimizing patient outcomes. I have illuminated the value of pharmacists in advancing access and success in patient care throughout my career, including documenting extensive evidence of the beneficial effects of pharmacist-provided direct patient care, with the support of ASHP and its members. Such evidence supports inclusion of pharmacists in interprofessional healthcare delivery models as a strategy to increase access, improve outcomes, and reduce healthcare costs.

To achieve this vision of access and success, we must recognize and respond to challenges facing the profession, including drug shortages, technological advances, financial sustainability, and workforce shortages, stress, and burnout. We must work together to build bridges to success in each of these areas. Further, we should amplify equitable healthcare for all patients and communities we serve. And we should strive to promote access and success by:

  • Advocating for pharmacists to practice at the top of their license and for improved reimbursement mechanisms.
  • Supporting the well-being of patients and the pharmacy workforce, including reducing burnout and stress.
  • Facilitating growth of the pharmacy technician workforce.
  • Expanding practice and care delivery, including greater participation on interprofessional healthcare teams.
  • Eliminating healthcare disparities and advancing equity for all.

I am honored to be nominated for the ASHP Board of Directors. It would be my privilege to serve our esteemed membership.